BIOBLAST PHARMA LTD's ticker is and the CUSIP is M20156119. A total of 3 filers reported holding BIOBLAST PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $101,000 | -35.7% | 130,128 | +11.6% | 0.00% | – |
| Q3 2018 | $157,000 | -55.9% | 116,628 | -40.9% | 0.00% | – |
| Q2 2018 | $356,000 | +86.4% | 197,420 | +104.2% | 0.00% | – |
| Q1 2018 | $191,000 | +7.3% | 96,660 | +23.8% | 0.00% | – |
| Q4 2017 | $178,000 | +67.9% | 78,060 | +58.8% | 0.00% | – |
| Q3 2017 | $106,000 | – | 49,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 197,420 | $356,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 200 | $0 | 0.00% |
| UBS Group AG | 2,224 | $4,000 | 0.00% |